Cabaletta Bio (CABA) Net Cash Flow Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 443.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 443.86% |
| Sep 30, 2025 | -966.77% |
| Jun 30, 2025 | 314.19% |
| Mar 31, 2025 | -79.10% |
| Dec 31, 2024 | -108.52% |
| Sep 30, 2024 | 36.32% |
| Jun 30, 2024 | -90.30% |
| Mar 31, 2024 | -246.63% |
| Dec 31, 2023 | 280.24% |
| Sep 30, 2023 | -189.83% |
| Jun 30, 2023 | 376.38% |
| Mar 31, 2023 | 119.53% |
| Dec 31, 2022 | 416.00% |
| Sep 30, 2022 | -25.42% |
| Jun 30, 2022 | -658.34% |
| Mar 31, 2022 | -1,409.37% |
| Dec 31, 2021 | 154.65% |
| Sep 30, 2021 | 649.01% |
| Jun 30, 2021 | 111.73% |
| Mar 31, 2021 | 20.17% |
| Dec 31, 2020 | -111.13% |
| Sep 30, 2020 | 18.95% |
| Jun 30, 2020 | -279.87% |
| Mar 31, 2020 | -111.01% |
| Dec 31, 2019 | 180.46% |